Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19

The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected nearly  every country and territory in the world. Although worldwide  vaccination efforts have reduced the risk of serious disease outcomes,  disparities in distribution have led to multiple waves of SARS-CoV-2  outbreaks and the emergence of variants of concern, some of which have  enhanced infectivity and ability to evade existing vaccines. Hence there  is an increasing interest in understanding the evolution of viruses  like SARS-CoV-2, as well as improving our capacity to effectively  current and manage future pandemics.
This new volume reviews the most  effective omic techniques for increasing our understanding of COVID-19,  to improve diagnostics, prognostics, and genomic surveillance, and to  facilitate development of effective treatments and vaccines. Chapters  are written by an international team of experts and explore methods in  the areas of genomics, transcriptomics, proteomics, and metabolomics.  Techniques used to assess physiological function at the molecular level  and artificial intelligence approaches used for more effective  validation and translation of biomarker candidates into clinical use are  also discussed. This book is an excellent resource for researchers  studying biomarkers, virology, metabolic diseases, and infectious  diseases, as well as clinical scientists, physicians, drug company  scientists, and healthcare workers.